Comparison of Single Time-Point [111-In] Pentetreotide SPECT/CT With Dual Time-Point Imaging of Neuroendocrine Tumors

Purpose: To determine whether single time-point single-photon emission computed tomography—computed tomography (SPECT/CT) somatostatin receptor imaging can replace traditional dual time-point planar and SPECT somatostatin receptor scintigraphy for evaluation of neuroendocrine tumors. Materials and Methods: Twenty-four patients (9 males, 15 females; mean age: 56 years; range: 14–82 years) underwent [111-In] pentetreotide scintigraphy, with planar...